Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma
出版年份 2019 全文链接
标题
Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma
作者
关键词
-
出版物
Frontiers in Genetics
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-09-18
DOI
10.3389/fgene.2019.00861
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining
- (2018) Putzer J. Hung et al. MOLECULAR CELL
- RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma
- (2017) E Viziteu et al. LEUKEMIA
- Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN
- (2017) Nausica Arnoult et al. NATURE
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- (2016) N. Weinhold et al. BLOOD
- A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells
- (2016) Arghya Ray et al. BRITISH JOURNAL OF HAEMATOLOGY
- Small RNAs Recruit Chromatin-Modifying Enzymes MMSET and Tip60 to Reconfigure Damaged DNA upon Double-Strand Break and Facilitate Repair
- (2016) Qinhong Wang et al. CANCER RESEARCH
- Targeting DNA Repair in Cancer: Beyond PARP Inhibitors
- (2016) Jessica S. Brown et al. Cancer Discovery
- PAXX Is an Accessory c-NHEJ Factor that Associates with Ku70 and Has Overlapping Functions with XLF
- (2016) Satish K. Tadi et al. Cell Reports
- Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study
- (2015) Peter M. Voorhees et al. BRITISH JOURNAL OF HAEMATOLOGY
- SnapShot: Multiple Myeloma
- (2015) Esteban Braggio et al. CANCER CELL
- Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage
- (2015) W. Wu et al. CANCER RESEARCH
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma
- (2015) Ruben Niesvizky et al. LEUKEMIA & LYMPHOMA
- A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition
- (2015) D. A. Alagpulinsa et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- Exploiting replicative stress to treat cancer
- (2015) Matthias Dobbelstein et al. NATURE REVIEWS DRUG DISCOVERY
- Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
- (2015) Marianne S. Poruchynsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma
- (2015) F. Cottini et al. Cancer Discovery
- Deregulation of DNA Double-Strand Break Repair in Multiple Myeloma: Implications for Genome Stability
- (2015) Ana B. Herrero et al. PLoS One
- A critical role for the NFkB pathway in multiple myeloma
- (2015) Oncotarget
- Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?
- (2015) Anouk Caraux et al. Oncotarget
- The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma
- (2015) Ken Maes et al. Oncotarget
- A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
- (2015) Alboukadel Kassambara et al. Oncotarget
- The future of autologous stem cell transplantation in myeloma
- (2014) F. van Rhee et al. BLOOD
- Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma
- (2014) S. K. Kumar et al. BLOOD
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- PJ34, a poly(ADP-ribose) polymerase (PARP) inhibitor, reverses melphalan-resistance and inhibits repair of DNA double-strand breaks by targeting the FA/BRCA pathway in multidrug resistant multiple myeloma cell line RPMI8226/R
- (2014) TING XIONG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks
- (2014) François Aymard et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions
- (2014) Manuel Luis Orta et al. NUCLEIC ACIDS RESEARCH
- A histone H3K36 chromatin switch coordinates DNA double-strand break repair pathway choice
- (2014) Chen-Chun Pai et al. Nature Communications
- Concerted Activities of Distinct H4K20 Methyltransferases at DNA Double-Strand Breaks Regulate 53BP1 Nucleation and NHEJ-Directed Repair
- (2014) Creighton T. Tuzon et al. Cell Reports
- SETD2-Dependent Histone H3K36 Trimethylation Is Required for Homologous Recombination Repair and Genome Stability
- (2014) Sophia X. Pfister et al. Cell Reports
- Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation
- (2014) Relja Popovic et al. PLoS Genetics
- DCEP for relapsed or refractory multiple myeloma after therapy with novel agents
- (2013) Silvia Park et al. ANNALS OF HEMATOLOGY
- Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer
- (2013) N J Curtin BRITISH JOURNAL OF PHARMACOLOGY
- Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma
- (2013) Caroline Bret et al. CELL CYCLE
- DNA repair pathways in human multiple myeloma
- (2013) Claire Gourzones-Dmitriev et al. CELL CYCLE
- Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe
- (2013) Mauro Cives et al. CELLULAR SIGNALLING
- Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other
- (2013) Sylvanie Surget et al. LEUKEMIA & LYMPHOMA
- Histone H4 deacetylation facilitates 53BP1 DNA damage signaling and double-strand break repair
- (2013) K.-Y. Hsiao et al. Journal of Molecular Cell Biology
- Repair of Strand Breaks by Homologous Recombination
- (2013) M. Jasin et al. Cold Spring Harbor Perspectives in Biology
- AZD5438, an Inhibitor of Cdk1, 2, and 9, Enhances the Radiosensitivity of Non-Small Cell Lung Carcinoma Cells
- (2012) Pavithra Raghavan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial
- (2012) Pieter Sonneveld et al. JOURNAL OF CLINICAL ONCOLOGY
- The Histone Methyltransferase MMSET Regulates Class Switch Recombination
- (2012) H. Pei et al. JOURNAL OF IMMUNOLOGY
- The Checkpoint Kinase Inhibitor AZD7762 Potentiates Chemotherapy-Induced Apoptosis of p53-Mutated Multiple Myeloma Cells
- (2012) H. J. Landau et al. MOLECULAR CANCER THERAPEUTICS
- Prime, Repair, Restore: The Active Role of Chromatin in the DNA Damage Response
- (2012) Gaston Soria et al. MOLECULAR CELL
- Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1)
- (2012) C. Boboila et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic lethality: exploiting the addiction of cancer to DNA repair
- (2011) M. Shaheen et al. BLOOD
- Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
- (2011) J. Martinez-Lopez et al. BLOOD
- RECQL1 and WRN Proteins Are Potential Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
- (2011) A. Arai et al. CANCER RESEARCH
- Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity
- (2011) Radek Jorda et al. JOURNAL OF MEDICINAL CHEMISTRY
- DNA mismatch repair status affects cellular response to Ara-C and other anti-leukemic nucleoside analogs
- (2011) S E Fordham et al. LEUKEMIA
- Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair
- (2011) Deniz Simsek et al. NATURE
- MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites
- (2011) Huadong Pei et al. NATURE
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition
- (2011) Neil Johnson et al. NATURE MEDICINE
- Wolf–Hirschhorn syndrome candidate 1 is involved in the cellular response to DNA damage
- (2011) Ildiko Hajdu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-Homologous End-Joining Gene Profiling Reveals Distinct Expression Patterns Associated with Lymphoma and Multiple Myeloma
- (2010) Philippa L. Roddam et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chaperoning Histones during DNA Replication and Repair
- (2010) Monica Ransom et al. CELL
- Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
- (2010) Marco Ladetto et al. JOURNAL OF CLINICAL ONCOLOGY
- 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination
- (2010) Anne Bothmer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
- (2010) Michele Cavo et al. LANCET
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- NHEJ and its backup pathways in chromosomal translocations
- (2010) Michael R Lieber NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining
- (2010) S. Fnu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of double-strand break repair in somatic mammalian cells
- (2009) Andrea J. Hartlerode et al. BIOCHEMICAL JOURNAL
- Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan
- (2009) C Dumontet et al. BONE MARROW TRANSPLANTATION
- DNA interstrand crosslink repair in mammalian cells: step by step
- (2009) Parameswary A Muniandy et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the Substrate
- (2009) Yan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased Plasma-Immune Cytokines throughout the High-Dose Melphalan-Induced Lymphodepletion in Patients with Multiple Myeloma: A Window for Adoptive Immunotherapy
- (2009) M. Condomines et al. JOURNAL OF IMMUNOLOGY
- Impairment of APE1 Function Enhances Cellular Sensitivity to Clinically Relevant Alkylators and Antimetabolites
- (2009) D. R. McNeill et al. MOLECULAR CANCER RESEARCH
- Dysfunctional homologous recombination mediates genomic instability and progression in myeloma
- (2008) M. A. Shammas et al. BLOOD
- Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models
- (2008) Kazunobu Futami et al. CANCER SCIENCE
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- Genome instability: a mechanistic view of its causes and consequences
- (2008) Andrés Aguilera et al. NATURE REVIEWS GENETICS
- Single-strand break repair and genetic disease
- (2008) Keith W. Caldecott NATURE REVIEWS GENETICS
- Transcription-coupled DNA repair: two decades of progress and surprises
- (2008) Philip C. Hanawalt et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
- (2008) K Hatano et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started